vimarsana.com

Page 11 - கனடா தொழில்துறை ஆராய்ச்சி உதவி ப்ரோக்ர்யாம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Relay Medical & Fio Execute Agreement to Provide COVID-19 Rapid Testing at Toronto Pearson International Airport

Relay” or the “ Fio”) – together through their joint venture company Fionet Rapid Response Group Inc (“ FRR”) – are pleased to announce that further to its press release on February 24, FRR and the Greater Toronto Airports Authority (GTAA) have executed the aforementioned agreement which sees the Fionet Pandemic Management Platform deployed for on-site COVID-19 rapid testing and real-time reporting at Toronto - Lester B. Pearson International Airport (“Toronto Pearson”). This multi-million-dollar program, with direct application to testing staff and restoring flights departing Toronto Pearson, is funded by the Government of Canada through the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP).

Relay Medical Corp : Relay Medical & Fio Execute Agreement to Provide COVID-19 Rapid Testing at Toronto Pearson International Airport

Relay Medical Corp : Relay Medical & Fio Execute Agreement to Provide COVID-19 Rapid Testing at Toronto Pearson International Airport
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Made-in-Alberta COVID-19 vaccine candidate goes to clinical trials

Date Time Made-in-Alberta COVID-19 vaccine candidate goes to clinical trials A made-in-Alberta COVID-19 vaccine is taking a major step forward on the path to Health Canada approval with the start of a Phase 1 clinical trial. Entos Pharmaceuticals, an Edmonton company led by CEO and University of Alberta researcher John Lewis, has shipped a vaccine for testing to the Canadian Centre for Vaccinology in Halifax. The clinical trial will test the safety of the DNA-based vaccine in 72 participants, split between young adults and older Canadians, with the aim of moving into a larger Phase 2 trial testing efficacy of the vaccine by late spring.

Alberta-made COVID-19 vaccine candidate heading into clinical trials

Phase 1 clinical trial for Alberta-made COVID-19 vaccine candidate ‘imminent’ © Global News An employee at Entos Pharmaceuticals Edmonton lab works on developing a COVID-19 vaccine. EDITOR S NOTE: The University of Alberta originally stated the Alberta-made vaccine was heading into clinical trials. However, Entos later clarified it has not been given the green light yet, but that Phase 1 was imminent. A made-in-Alberta COVID-19 vaccine candidate is ready to head into Phase 1 of a clinical trial in hopes it will eventually be approved for use by Health Canada. Edmonton-based Entos Pharmaceuticals, led by University of Alberta researcher Dr. John Lewis, has shipped a vaccine for testing to the Canadian Centre of Vaccinology in Halifax.

Nano One Materials Corp : Nano One Launches Groundbreaking M2CAM Technology to Reduce Cost, Waste and Carbon Footprint in Lithium-Ion Battery Supply Chain

Nano One Materials Corp : Nano One Launches Groundbreaking M2CAM Technology to Reduce Cost, Waste and Carbon Footprint in Lithium-Ion Battery Supply Chain
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.